Cubio, Arabella Jean G.

HRN: 22-49-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/15/2023
01/22/2023
IVT
150 Mg
24 Hrs
PCAP C
Waiting Final Action 
01/15/2023
CEFTRIAXONE 1G (VIAL)
01/15/2023
01/22/2023
IVT
1 G
24 Hrs
PCAP C
Waiting Final Action 
01/20/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/20/2023
01/26/2023
IV DRIP
1gm
Q6
PCAP C
Waiting Final Action 
01/20/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
01/20/2023
01/26/2023
IVT
50mg
Q24
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: